The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM Stephen B. EdgeCarolyn C. Compton Healthcare Policy and Outcomes 24 February 2010 Pages: 1471 - 1474
2010 TNM Staging System for Cutaneous Melanoma…and Beyond Jeffrey E. GershenwaldSeng-jaw SoongOn behalf of the American Joint Committee on Cancer (AJCC) Melanoma Staging Committee Melanomas 19 March 2010 Pages: 1475 - 1477
Do Practice Patterns Reflect Practice Guidelines? Tina W. F. YenDouglas B. Evans Healthcare Policy and Outcomes 16 March 2010 Pages: 1478 - 1480
Are Radical Compartmental Resections for Retroperitoneal Sarcomas Justified? Chandrajit P. RautCarol J. Swallow Bone and Soft Tissue Sarcomas 17 April 2010 Pages: 1481 - 1484
When is Age More Than Just a Number? Kathleen DiehlLisa A. Newman Breast Oncology 17 April 2010 Pages: 1485 - 1486
Age does not Preclude an Esophagectomy…If Only it were that Simple Mark B. Orringer Thoracic Oncology 09 March 2010 Pages: 1487 - 1489
Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines? Babita PanigrahiSanziana A. RomanJulie Ann Sosa Healthcare Policy and Outcomes 12 March 2010 Pages: 1490 - 1498
Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case–Control Study Roy F. ChemalyRay Y. HachemIssam I. Raad Healthcare Policy and Outcomes 03 February 2010 Pages: 1499 - 1506
Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control Sylvie BonvalotRosalba MiceliAlessandro Gronchi Bone and Soft Tissue Sarcomas 15 April 2010 Pages: 1507 - 1514
Proton-Beam, Intensity-Modulated, and/or Intraoperative Electron Radiation Therapy Combined with Aggressive Anterior Surgical Resection for Retroperitoneal Sarcomas Sam S. YoonYen-Lin ChenThomas F. DeLaney Bone and Soft Tissue Sarcomas 12 February 2010 Pages: 1515 - 1529
Management of Operable Invasive Breast Cancer in Women Over the Age of 70: Long-Term Results of a Large-Scale Single-Institution Experience Fatima LakiYoulia M. KirovaRemy J. Salmon Breast Oncology 23 February 2010 Pages: 1530 - 1538
Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery Maria T. SandriLaura ZorzinoFranco Nolè Breast Oncology 05 February 2010 Pages: 1539 - 1545
Liver Resection for Multimodal Treatment of Breast Cancer Metastases: Identification of Prognostic Factors Katrin HoffmannClemens FranzPeter Schemmer Breast Oncology 09 February 2010 Pages: 1546 - 1554
Prognostic Significance of c-erbB-2 and Vascular Endothelial Growth Factor in Colorectal Liver Metastases Jinggui ChenQingguo LiGuangfa Zhao Hepatobiliary Tumors 13 January 2010 Pages: 1555 - 1563
Hepatocellular Carcinomas in Cirrhotic and Noncirrhotic Human Livers Share Angiogenic Characteristics Wenjiao ZengAnnette S. H. GouwKoert P. de Jong Hepatobiliary Tumors Open access 20 January 2010 Pages: 1564 - 1571
Extended Esophagectomy in Elderly Patients with Esophageal Cancer: Minor Effect of Age Alone in Determining the Postoperative Course and Survival B. B. PultrumD. J. BoschJ. Th. M. Plukker Gastrointestinal Oncology Open access 24 February 2010 Pages: 1572 - 1580
Variations in Surgeon Treatment Recommendations for Lobectomy in Early-Stage Non-Small-Cell Lung Cancer by Patient Age and Comorbidity Selwyn O. Rogers Jr.Stacy W. GrayNancy L. Keating Thoracic Oncology 17 February 2010 Pages: 1581 - 1588
Effect of Age on Surgical Outcomes of Extended Gastrectomy With D2 Lymph Node Dissection in Gastric Carcinoma: Prospective Cohort Study Oh JeongYoung Kyu ParkYoung Jin Kim Gastrointestinal Oncology 23 January 2010 Pages: 1589 - 1596
Risk Factors for Lymph Node Metastasis from Gastric Cancers with Submucosal Invasion Yusuke TajimaMasahiko MurakamiTakashi Kato Gastrointestinal Oncology 04 February 2010 Pages: 1597 - 1604
Laparoscopic Total Gastrectomy and D2 Lymphadenectomy Giovanni DapriJacques HimpensGuy-Bernard Cadière Gastrointestinal Oncology 03 March 2010 Pages: 1605 - 1605
Body Mass Index does not Affect Postoperative Morbidity and Oncologic Outcomes of Total Mesorectal Excision for Rectal Adenocarcinoma Nikiforos BallianBrett YamaneGregory D. Kennedy Colorectal Cancer 15 January 2010 Pages: 1606 - 1613
Multicentric Study on Robotic Tumor-Specific Mesorectal Excision for the Treatment of Rectal Cancer Alessio PigazziFabrizio LucaJeong-Heum Baek Colorectal Cancer 20 January 2010 Pages: 1614 - 1620
Parenchyma-Preserving Resections for Small Nonfunctioning Pancreatic Endocrine Tumors Massimo FalconiAlessandro ZerbiPaolo Pederzoli Pancreatic Tumors 17 February 2010 Pages: 1621 - 1627
New Operative Surgical Concept of Two Fascial Layers Enveloping the Recurrent Laryngeal Nerve Jonathan W. Serpell Endocrine Tumors 09 February 2010 Pages: 1628 - 1636
Prophylactic Lymphadenectomy of Neck Level II in Clinically Node-Positive Papillary Thyroid Carcinoma Bon Seok KooSung-Tae SeoYoung Chang Lim Endocrine Tumors 10 February 2010 Pages: 1637 - 1641
Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease Pauline WimbergerMichael WehlingAndreas du Bois Gynecologic Oncology 18 February 2010 Pages: 1642 - 1648
Increased Use of Percutaneous Technique for Totally Implantable Venous Access Devices. Is It Real Progress? A 27-Year Comprehensive Review on Early Complications Isidoro Di CarloElia PulvirentiAdriana Toro Medical Oncology 05 March 2010 Pages: 1649 - 1656
Utility of FDG PET/CT and Brain MRI in Melanoma Patients with Increased Serum S-100B Level During Follow-up Tjeerd S. AukemaRenato A. Valdés OlmosOmgo E. Nieweg Melanomas 12 February 2010 Pages: 1657 - 1661
Conditional Survival After Surgical Treatment of Melanoma: An Analysis of the Surveillance, Epidemiology, and End Results Database Natasha M. RuethShawn S. GrothElizabeth B. Habermann Melanomas 18 February 2010 Pages: 1662 - 1668
Skin-Sparing Mastectomy and Immediate Breast Reconstruction in the Management of Locally Recurrent Breast Cancer A. J. LindfordT. J. MeretojaT. A. Jahkola Reconstructive Oncology 12 February 2010 Pages: 1669 - 1674
Clinical Significance of Tumor Necrosis Factor Receptor Superfamily Member 11b Polymorphism in Prostate Cancer Bo-Ying BaoVictor C. LinShu-Pin Huang Urologic Oncology 04 March 2010 Pages: 1675 - 1681
Cervical Lymph Node Dissection for Metastatic Testicular Cancer M. G. van VledderJ. A. van der HageJ. H. W. de Wilt Urologic Oncology 24 March 2010 Pages: 1682 - 1687
Chromosomal Alterations in Pure Nonneoplastic Breast Lesions: Implications for Breast Cancer Progression Rachel E. EllsworthDarrell L. EllsworthCraig D. Shriver Translational Research and Biomarkers 27 January 2010 Pages: 1688 - 1694
Overexpression of Nuclear Protein Kinase CK2 β Subunit and Prognosis in Human Gastric Carcinoma Kai-Yuan LinChia-Lang FangYih-Huei Uen Translational Research and Biomarkers 20 January 2010 Pages: 1695 - 1702
Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma Yu-Jia ChangChong-Chi ChiuMing-Te Huang Translational Research and Biomarkers 20 January 2010 Pages: 1703 - 1709
Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Paul H. Sugarbaker Thoracic Oncology 31 March 2010 Pages: 1710 - 1712
In Reply: Five Reasons Why Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Must Be Regarded as the New Standard of Care for Diffuse Malignant Peritoneal Mesothelioma D. BarattiS. KusamuraM. Deraco Gastrointestinal Oncology 31 March 2010 Pages: 1713 - 1714
Chemoradiotherapy in Adenocarcinoma of the Stomach or Esophagus Christof HottenrottDimosthenis Ziogas Gastrointestinal Oncology 26 March 2010 Pages: 1715 - 1716
Should Chemoradiotherapy Be Used in Node-Negative Esophageal or Gastric Adenocarcinoma? Naveenraj L. SolomonLeonidas G. Koniaris Gastrointestinal Oncology 09 March 2010 Pages: 1717 - 1717
Does Metastatic Lymph Node Ratio Really Suit for Prognostic Prediction of the D1 Lymphadenectomy? Jingyu DengHan Liang Gastrointestinal Oncology 16 April 2010 Pages: 1718 - 1718
In Reply: Does Metastatic Lymph Node Ratio Really Suit for Prognostic Prediction of the D1 Lymphadenectomy? Ugwuji N. MaduekweSam S. Yoon Gastrointestinal Oncology 14 April 2010 Pages: 1719 - 1719
HER-2-Negative Breast Cancer Limitations and Next-Generation Sequencing Technology Promises Georgios BaltogiannisChristos KatsiosDimitrios H. Roukos Breast Oncology 03 March 2010 Pages: 1720 - 1720
